Lucid Diagnostics Inc Q3 2024 Earnings Revenue Beats Estimates at 1. ...
| LUCD Stock | USD 1.59 0.26 19.55% |
About 55% of Lucid Diagnostics' shareholders are presently thinking to get in. The analysis of overall sentiment of trading Lucid Diagnostics stock suggests that some investors are interested at this time. The current market sentiment, together with Lucid Diagnostics' historical and current headlines, can help investors time the market. In addition, many technical investors use Lucid Diagnostics stock news signals to limit their universe of possible portfolio assets.
Revenue Reported at 1.172 million for Q3 2024, slightly exceeding the analyst estimate of 1.14 million.Net Loss Recorded a net loss of 12.371 million for
Read at gurufocus.com
 |
Lucid Diagnostics Fundamental Analysis
We analyze Lucid Diagnostics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Lucid Diagnostics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Lucid Diagnostics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Operating Margin
Operating Margin Comparative Analysis
Lucid Diagnostics is currently under evaluation in operating margin category among its peers. Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Lucid Diagnostics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Lucid Diagnostics stock to make a market-neutral strategy. Peer analysis of Lucid Diagnostics could also be used in its relative valuation, which is a method of valuing Lucid Diagnostics by comparing valuation metrics with similar companies.
Peers
Lucid Diagnostics Related Equities
| XAIR | Beyond Air | 5.56 | ||||
| CVRX | CVRx | 0.30 | ||||
| ITGR | Integer Holdings | 0.13 | ||||
| LUNG | Pulmonx Corp | 0.32 | ||||
| NPCE | Neuropace | 1.06 | ||||
| OFIX | Orthofix Medical | 1.16 | ||||
| KIDS | Orthopediatrics Corp | 1.51 | ||||
| CLPT | Clearpoint Neuro | 1.57 | ||||
| SRDX | SurModics | 1.58 | ||||
| IRMD | Iradimed | 2.28 | ||||
| LIVN | LivaNova PLC | 3.01 | ||||
| ELMD | Electromed | 3.44 |
Complementary Tools for Lucid Stock analysis
When running Lucid Diagnostics' price analysis, check to measure Lucid Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lucid Diagnostics is operating at the current time. Most of Lucid Diagnostics' value examination focuses on studying past and present price action to predict the probability of Lucid Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lucid Diagnostics' price. Additionally, you may evaluate how the addition of Lucid Diagnostics to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Stocks Directory Find actively traded stocks across global markets | |
| Global Correlations Find global opportunities by holding instruments from different markets |